Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 30, Issue 8
  5. Article
Volume 30, Issue 8
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Heart Failure (HF) remains a global health challenge, marked by its widespread prevalence and substantial resource utilization. Although the prognosis has improved in recent decades due to the treatments implemented, it continues to generate high morbidity and mortality in the medium to long term. Interventional cardiology has emerged as a crucial player in HF management, offering a diverse array of percutaneous treatments for both acute and chronic HF. This article aimed to provide a comprehensive review of the role of percutaneous interventions in HF patients, with a primary focus on key features, clinical effectiveness, and safety outcomes. Despite the growing utilization of these interventions, there remain critical gaps in the existing body of evidence. Consequently, the need for high-quality randomized clinical trials and extensive international registries is emphasized to shed light on the specific patient populations and clinical scenarios that stand to benefit most from these innovative devices.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128284131240209113009
2024-03-01
2024-11-06

  • From This Site

    /content/journals/cpd/10.2174/0113816128284131240209113009
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. McDonaghT.A. MetraM. AdamoM. GardnerR.S. BaumbachA. BöhmM. BurriH. ButlerJ. ČelutkienėJ. ChioncelO. ClelandJ.G.F. CoatsA.J.S. Crespo-LeiroM.G. FarmakisD. GilardM. HeymansS. HoesA.W. JaarsmaT. JankowskaE.A. LainscakM. LamC.S.P. LyonA.R. McMurrayJ.J.V. MebazaaA. MindhamR. MunerettoC. Francesco PiepoliM. PriceS. RosanoG.M.C. RuschitzkaF. Kathrine SkibelundA. de BoerR.A. Christian SchulzeP. AbdelhamidM. AboyansV. AdamopoulosS. AnkerS.D. ArbeloE. AsteggianoR. BauersachsJ. Bayes-GenisA. BorgerM.A. BudtsW. CikesM. DammanK. DelgadoV. DendaleP. DilaverisP. DrexelH. EzekowitzJ. FalkV. FauchierL. FilippatosG. FraserA. FreyN. GaleC.P. GustafssonF. HarrisJ. IungB. JanssensS. JessupM. KonradiA. KotechaD. LambrinouE. LancellottiP. LandmesserU. LeclercqC. LewisB.S. LeyvaF. LinhartA. LøchenM-L. LundL.H. ManciniD. MasipJ. MilicicD. MuellerC. NefH. NielsenJ-C. NeubeckL. NoutsiasM. PetersenS.E. Sonia PetronioA. PonikowskiP. PrescottE. RakishevaA. RichterD.J. SchlyakhtoE. SeferovicP. SenniM. SitgesM. Sousa-UvaM. TocchettiC.G. TouyzR.M. TschoepeC. WaltenbergerJ. AdamoM. BaumbachA. BöhmM. BurriH. ČelutkienėJ. ChioncelO. ClelandJ.G.F. CoatsA.J.S. Crespo-LeiroM.G. FarmakisD. GardnerR.S. GilardM. HeymansS. HoesA.W. JaarsmaT. JankowskaE.A. LainscakM. LamC.S.P. LyonA.R. McMurrayJ.J.V. MebazaaA. MindhamR. MunerettoC. PiepoliM.F. PriceS. RosanoG.M.C. RuschitzkaF. SkibelundA.K. ESC Scientific Document Group 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur. Heart J.202142363599372610.1093/eurheartj/ehab36834447992
     [Google Scholar]
  2. HeidenreichP.A. BozkurtB. AguilarD. AllenL.A. ByunJ.J. ColvinM.M. DeswalA. DraznerM.H. DunlayS.M. EversL.R. FangJ.C. FedsonS.E. FonarowG.C. HayekS.S. HernandezA.F. KhazanieP. KittlesonM.M. LeeC.S. LinkM.S. MilanoC.A. NnachetaL.C. SandhuA.T. StevensonL.W. VardenyO. VestA.R. YancyC.W. 2022 AHA/ACC/HFSA guideline for the management of heart failure.J. Am. Coll. Cardiol.20227917e263e42110.1016/j.jacc.2021.12.01235379503
     [Google Scholar]
  3. EltayebM. SquireI. SzeS. Biomarkers in heart failure: A focus on natriuretic peptides. Heart.202310.1136/heartjnl‑2020‑318553
     [Google Scholar]
  4. LanT. LiaoY.H. ZhangJ. YangZ.P. XuG.S. ZhuL. FanD.M. Mortality and readmission rates after heart failure: A systematic review and meta-analysis.Ther. Clin. Risk Manag.2021171307132010.2147/TCRM.S34058734908840
     [Google Scholar]
  5. TaylorC.J. Ordóñez-MenaJ.M. RoalfeA.K. Lay-FlurrieS. JonesN.R. MarshallT. HobbsF.D.R. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: Population based cohort study.BMJ2019364l22310.1136/bmj.l22330760447
     [Google Scholar]
  6. VahdatpourC. CollinsD. GoldbergS. Cardiogenic shock.J. Am. Heart Assoc.201988e01199110.1161/JAHA.119.01199130947630
     [Google Scholar]
  7. LeeJ.M. RheeT.M. HahnJ.Y. KimH.K. ParkJ. HwangD. ChoiK.H. KimJ. ParkT.K. YangJ.H. SongY.B. ChoiJ.H. ChoiS.H. KooB.K. KimY.J. ChaeS.C. ChoM.C. KimC.J. GwonH.C. KimJ.H. KimH.S. JeongM.H. KAMIR Investigators Multivessel percutaneous coronary intervention in patients with st-segment elevation myocardial infarction with cardiogenic shock.J. Am. Coll. Cardiol.201871884485610.1016/j.jacc.2017.12.02829471935
     [Google Scholar]
  8. AlbaA.C. RaoV. IvanovJ. RossH.J. DelgadoD.H. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.J. Heart Lung Transplant.200928882783310.1016/j.healun.2009.04.03319632580
     [Google Scholar]
  9. LawtonJ.S. Tamis-HollandJ.E. BangaloreS. BatesE.R. BeckieT.M. BischoffJ.M. BittlJ.A. CohenM.G. DiMaioJ.M. DonC.W. FremesS.E. GaudinoM.F. GoldbergerZ.D. GrantM.C. JaswalJ.B. KurlanskyP.A. MehranR. MetkusT.S.Jr NnachetaL.C. RaoS.V. SellkeF.W. SharmaG. YongC.M. ZwischenbergerB.A. Writing Committee Members 2021 ACC/AHA/SCAI guideline for coronary artery revascularization.J. Am. Coll. Cardiol.2022792e21e12910.1016/j.jacc.2021.09.00634895950
     [Google Scholar]
  10. PapaioannouT.G. StefanadisC. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance.ASAIO J.200551329630010.1097/01.MAT.0000159381.97773.9B15968962
     [Google Scholar]
  11. ThieleH. ZeymerU. ThelemannN. NeumannF.J. HausleiterJ. Abdel-WahabM. Meyer-SaraeiR. FuernauG. EitelI. HambrechtR. BöhmM. WerdanK. FelixS.B. HennersdorfM. SchneiderS. OuarrakT. DeschS. de Waha-ThieleS. AlkisogluZ. FollathF. FreyS. HaertingJ. HuberK. MaischB. MessemerB. OurrakT. SchulerG. VonderschmittK. WerdanK. IABP-SHOCK II Trial (Intraaortic Balloon Pump in Cardiogenic Shock II) Investigators IABP-SHOCK II Investigators Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction.Circulation2019139339540310.1161/CIRCULATIONAHA.118.03820130586721
     [Google Scholar]
  12. VargasK.G. JägerB. KaufmannC.C. BiagioliA. WatremezS. GattoF. ÖzbekC. RazoukA. GeppertA. HuberK. Impella in cardiogenic shock following acute myocardial infarction: A systematic review and meta-analysis.Wien. Klin. Wochenschr.202013223-2471672510.1007/s00508‑020‑01712‑y32691215
     [Google Scholar]
  13. ZeinR. PatelC. Mercado-AlamoA. SchreiberT. KakiA. A review of the Impella devices.Interv. Cardiol.202217e0510.15420/icr.2021.1135474971
     [Google Scholar]
  14. AndersonM.B. GoldsteinJ. MilanoC. MorrisL.D. KormosR.L. BhamaJ. KapurN.K. BansalA. GarciaJ. BakerJ.N. SilvestryS. HolmanW.L. DouglasP.S. O’NeillW. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device.J. Heart Lung Transplant.201534121549156010.1016/j.healun.2015.08.01826681124
     [Google Scholar]
  15. ZeinR. A review of the Impella devices.2021Available from: https://www.icrjournal.com/articles/review-impella-devices
    [Google Scholar]
  16. Impella ventricular support systems.Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/p140003s018d.pdf
  17. SinghV. YadavP.K. EngM.H. MacedoF.Y. SilvaG.V. MendirichagaR. BadiyeA.P. SakhujaR. ElmariahS. InglessisI. AlfonsoC.E. SchreiberT.L. CohenM. PalaciosI. O’NeillW.W. Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry.Int. J. Cardiol.201724012012510.1016/j.ijcard.2017.03.07128377189
     [Google Scholar]
  18. Impella ECP early feasibility study - Full text view.Available from: https://clinicaltrials.gov/ct2/show/NCT04477603
  19. SeyfarthM. SibbingD. BauerI. FröhlichG. Bott-FlügelL. ByrneR. DirschingerJ. KastratiA. SchömigA. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.J. Am. Coll. Cardiol.200852191584158810.1016/j.jacc.2008.05.06519007597
     [Google Scholar]
  20. OuweneelD.M. EriksenE. SjauwK.D. van DongenI.M. HirschA. PackerE.J.S. VisM.M. WykrzykowskaJ.J. KochK.T. BaanJ. de WinterR.J. PiekJ.J. LagrandW.K. de MolB.A.J.M. TijssenJ.G.P. HenriquesJ.P.S. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.J. Am. Coll. Cardiol.201769327828710.1016/j.jacc.2016.10.02227810347
     [Google Scholar]
  21. SchrageB. IbrahimK. LoehnT. WernerN. SinningJ.M. PappalardoF. PieriM. SkurkC. LautenA. LandmesserU. WestenfeldR. HornP. PauschingerM. EcknerD. TwerenboldR. NordbeckP. SalingerT. AbelP. EmpenK. BuschM.C. FelixS.B. SiewekeJ.T. MøllerJ.E. PareekN. HillJ. MacCarthyP. BergmannM.W. HenriquesJ.P.S. Möbius-WinklerS. SchulzeP.C. OuarrakT. ZeymerU. SchneiderS. BlankenbergS. ThieleH. SchäferA. WestermannD. Impella support for acute myocardial infarction complicated by cardiogenic shock.Circulation2019139101249125810.1161/CIRCULATIONAHA.118.03661430586755
     [Google Scholar]
  22. O’NeillW.W. KleimanN.S. MosesJ. HenriquesJ.P.S. DixonS. MassaroJ. PalaciosI. MainiB. MulukutlaS. DžavíkV. PopmaJ. DouglasP.S. OhmanM. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study.Circulation2012126141717172710.1161/CIRCULATIONAHA.112.09819422935569
     [Google Scholar]
  23. KuchibhotlaS. EspositoM.L. BretonC. PediciniR. MullinA. O’KellyR. AndersonM. MorrisD.L. BatsidesG. RamzyD. GriseM. PhamD.T. KapurN.K. Acute biventricular mechanical circulatory support for cardiogenic shock.J. Am. Heart Assoc.2017610e00667010.1161/JAHA.117.00667029054842
     [Google Scholar]
  24. CheungA.W. WhiteC.W. DavisM.K. FreedD.H. Short-term mechanical circulatory support for recovery from acute right ventricular failure: Clinical outcomes.J. Heart Lung Transplant.201433879479910.1016/j.healun.2014.02.02824726682
     [Google Scholar]
  25. PivatoC.A. FerranteG. BrianiM. Sanz SanchezJ. ReimersB. PagnottaP. Mitraclip treatment for severe mitral regurgitation due to chordae rupture following Impella CP support in a patient with severe aortic stenosis.Cardiovasc. Revasc. Med.20212811812010.1016/j.carrev.2020.08.02732855084
     [Google Scholar]
  26. AragonJ. LeeM.S. KarS. MakkarR.R. Percutaneous left ventricular assist device: “TandemHeart” for high-risk coronary intervention.Catheter. Cardiovasc. Interv.200565334635210.1002/ccd.2033915945107
     [Google Scholar]
  27. BurkhoffD. CohenH. BrunckhorstC. O’NeillW.W. TandemHeart Investigators Group A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.Am. Heart J.20061523469.e1469.e810.1016/j.ahj.2006.05.03116923414
     [Google Scholar]
  28. ThieleH. SickP. BoudriotE. DiederichK.W. HambrechtR. NiebauerJ. SchulerG. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.Eur. Heart J.200526131276128310.1093/eurheartj/ehi16115734771
     [Google Scholar]
  29. GieslerG.M. GomezJ.S. LetsouG. VooletichM. SmallingR.W. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction.Catheter. Cardiovasc. Interv.200668226326610.1002/ccd.2084616819772
     [Google Scholar]
  30. TakagakiM. WurzerC. WadeR. LeeR. MalaisrieS.C. McCarthyP.M. McGeeE.C.Jr Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE.Ann. Thorac. Surg.20088651677167910.1016/j.athoracsur.2008.04.10119049776
     [Google Scholar]
  31. BajonaP. SalizzoniS. BrannS.H. CoyneJ. BermudezC. KormosR. ToyodaY. Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation.J. Thorac. Cardiovasc. Surg.20101393e53e5410.1016/j.jtcvs.2008.10.04219660327
     [Google Scholar]
  32. RajdevS. BenzaR. MisraV. Use of tandem heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock.J. Invasive Cardiol.2007198E226E22917712211
     [Google Scholar]
  33. KapurN.K. EspositoM.L. BaderY. MorineK.J. KiernanM.S. PhamD.T. BurkhoffD. Mechanical circulatory support devices for acute right ventricular failure.Circulation2017136331432610.1161/CIRCULATIONAHA.116.02529028716832
     [Google Scholar]
  34. RavichandranAK BaranDA StellingK CowgerJA SalernoCT Outcomes with the tandem protek duo dual-lumen percutaneous right ventricular assist device.ASAIO J Am Soc Artif Intern Organs 19921992644570572
     [Google Scholar]
  35. CombesA. PriceS. SlutskyA.S. BrodieD. Temporary circulatory support for cardiogenic shock.Lancet20203961024519921210.1016/S0140‑6736(20)31047‑332682486
     [Google Scholar]
  36. SheuJ.J. TsaiT.H. LeeF.Y. FangH.Y. SunC.K. LeuS. YangC.H. ChenS.M. HangC.L. HsiehY.K. ChenC.J. WuC.J. YipH.K. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock.Crit. Care Med.20103891810181710.1097/CCM.0b013e3181e8acf720543669
     [Google Scholar]
  37. OuweneelD.M. SchotborghJ.V. LimpensJ. SjauwK.D. EngströmA.E. LagrandW.K. CherpanathT.G.V. DriessenA.H.G. de MolB.A.J.M. HenriquesJ.P.S. Extracorporeal life support during cardiac arrest and cardiogenic shock: A systematic review and meta-analysis.Intensive Care Med.201642121922193410.1007/s00134‑016‑4536‑827647331
     [Google Scholar]
  38. RupprechtL. LunzD. PhilippA. LubnowM. SchmidC. Pitfalls in percutaneous ECMO cannulation.Heart Lung Vessel.20157432032626811838
     [Google Scholar]
  39. ConradS.A. GrierL.R. ScottL.K. GreenR. JordanM. Percutaneous cannulation for extracorporeal membrane oxygenation by intensivists: A retrospective single-institution case series.Crit. Care Med.20154351010101510.1097/CCM.000000000000088325746749
     [Google Scholar]
  40. MakdisiG. WangI.W. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology.J. Thorac. Dis.201577E166E17626380745
     [Google Scholar]
  41. RussoJ.J. AleksovaN. PitcherI. CoutureE. ParlowS. FarazM. VisintiniS. SimardT. Di SantoP. MathewR. SoD.Y. TakedaK. GaranA.R. KarmpaliotisD. TakayamaH. KirtaneA.J. HibbertB. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock.J. Am. Coll. Cardiol.201973665466210.1016/j.jacc.2018.10.08530765031
     [Google Scholar]
  42. SchrageB. BurkhoffD. RübsamenN. BecherP.M. SchwarzlM. BernhardtA. GrahnH. LubosE. SöffkerG. ClemmensenP. ReichenspurnerH. BlankenbergS. WestermannD. Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock.JACC Heart Fail.20186121035104310.1016/j.jchf.2018.09.00930497643
     [Google Scholar]
  43. CevascoM. TakayamaH. AndoM. GaranA.R. NakaY. TakedaK. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation.J. Thorac. Dis.20191141676168310.21037/jtd.2019.03.2931179113
     [Google Scholar]
  44. PasrijaC. BedeirK. JeudyJ. KonZ.N. Harlequin syndrome during venoarterial extracorporeal membrane oxygenation.Radiol. Cardiothorac. Imaging201912e19003110.1148/ryct.201919003133778505
     [Google Scholar]
  45. GroenewegenA. RuttenF.H. MosterdA. HoesA.W. Epidemiology of heart failure.Eur. J. Heart Fail.20202281342135610.1002/ejhf.185832483830
     [Google Scholar]
  46. van RietE.E.S. HoesA.W. LimburgA. LandmanM.A.J. van der HoevenH. RuttenF.H. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion.Eur. J. Heart Fail.201416777277710.1002/ejhf.11024863953
     [Google Scholar]
  47. van RietE.E.S. HoesA.W. WagenaarK.P. LimburgA. LandmanM.A.J. RuttenF.H. Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.Eur. J. Heart Fail.201618324225210.1002/ejhf.48326727047
     [Google Scholar]
  48. StolfoD. UijlA. VedinO. StrömbergA. FaxénU.L. RosanoG.M.C. SinagraG. DahlströmU. SavareseG. Sex-based differences in heart failure across the ejection fraction spectrum.JACC Heart Fail.20197650551510.1016/j.jchf.2019.03.01131146874
     [Google Scholar]
  49. ConradN. JudgeA. TranJ. MohseniH. HedgecottD. CrespilloA.P. AllisonM. HemingwayH. ClelandJ.G. McMurrayJ.J.V. RahimiK. Temporal trends and patterns in heart failure incidence: A population-based study of 4 million individuals.Lancet20183911012057258010.1016/S0140‑6736(17)32520‑529174292
     [Google Scholar]
  50. McDonaghT.A. MetraM. AdamoM. GardnerR.S. BaumbachA. BöhmM. BurriH. ButlerJ. ČelutkienėJ. ChioncelO. ClelandJ.G.F. Crespo-LeiroM.G. FarmakisD. GilardM. HeymansS. HoesA.W. JaarsmaT. JankowskaE.A. LainscakM. LamC.S.P. LyonA.R. McMurrayJ.J.V. MebazaaA. MindhamR. MunerettoC. Francesco PiepoliM. PriceS. RosanoG.M.C. RuschitzkaF. SkibelundA.K. de BoerR.A. SchulzeP.C. ArbeloE. BartunekJ. BauersachsJ. BorgerM.A. BuccheriS. CerbaiE. DonalE. EdelmannF. FärberG. HeideckerB. IbanezB. JamesS. KøberL. KoskinasK.C. MasipJ. McEvoyJ.W. MentzR. MihaylovaB. MøllerJ.E. MullensW. NeubeckL. NielsenJ.C. PasquetA.A. PonikowskiP. PrescottE. RakishevaA. RoccaB. RosselloX. SadeL.E. SchaubroeckH. TessitoreE. TokmakovaM. van der MeerP. Van GelderI.C. Van HeetveldeM. VrintsC. WilhelmM. WitkowskiA. ZeppenfeldK. ShukaN. ChettibiM. HayrapetyanH. PavoN. IslamliA. PouleurA-C. KusljugicZ. TokmakovaM. MilicicD. ChristodoulidesT. MalekF. KøberL. KoriemM.A.G. PõderP. LassusJ. RoubilleF. AgladzeV. FrantzS. StavratiA. KosztinA. IngimarsdóttirI.J. CampbellP. HasinT. OlivaF. AidargaliyevaN. BajraktariG. MirrakhimovE. KamzolaG. El NeihoumA.M. ZaliaduonyteD. MooreA. VatamanE. BoskovicA. AlamiM. ManintveldO. KostovskaE.S. BrochK. NesslerJ. FrancoF. PopescuB.A. FoscoliM. MilosavljevicA.S. GoncalvesovaE. FrasZ. Gonzalez-CostelloJ. LindmarkK. PaulM. OudehA. ZakhamaL. CelikA. VoronkovL. ClarkA. AbdullaevT. PrescottE. JamesS. ArbeloE. BaigentC. BorgerM.A. BuccheriS. IbanezB. KøberL. KoskinasK.C. McEvoyJ.W. MihaylovaB. MindhamR. NeubeckL. NielsenJ.C. PasquetA.A. RakishevaA. RoccaB. RosselloX. VaartjesI. VrintsC. WitkowskiA. ZeppenfeldK. ESC Scientific Document Group 2023 focused update of the 2021 esc guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur. Heart J.202344373627363910.1093/eurheartj/ehad19537622666
     [Google Scholar]
  51. Martinez-SoleJ. Sanchez-MartinezJ.C. Lopez-VilellaR. Donoso-TrenadoV. Sanchez-LazaroI. Almenar-BonetL. Sanz-SanchezJ. Martinez-DolzL. Overview of the treatment of congestion in heart failure.Curr. Pharm. Des.202329201592160110.2174/138161282966623071415340437455461
     [Google Scholar]
  52. GoliaschG. BartkoP.E. PavoN. NeuholdS. WurmR. MascherbauerJ. LangI.M. StrunkG. HülsmannM. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.Eur. Heart J.2018391394610.1093/eurheartj/ehx40229020337
     [Google Scholar]
  53. AsmaratsL. TaramassoM. Rodés-CabauJ. Tricuspid valve disease: Diagnosis, prognosis and management of a rapidly evolving field.Nat. Rev. Cardiol.201916953855410.1038/s41569‑019‑0186‑130988448
     [Google Scholar]
  54. GoelS.S. BajajN. AggarwalB. GuptaS. PoddarK.L. IgeM. BdairH. AnabtawiA. RahimS. WhitlowP.L. TuzcuE.M. GriffinB.P. StewartW.J. GillinovM. BlackstoneE.H. SmediraN.G. OliveiraG.H. BarzilaiB. MenonV. KapadiaS.R. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: Comprehensive analysis to determine the potential role of MitraClip for this unmet need.J. Am. Coll. Cardiol.201463218518610.1016/j.jacc.2013.08.72324036029
     [Google Scholar]
  55. RossiA. DiniF.L. FaggianoP. AgricolaE. CicoiraM. FrattiniS. SimioniucA. GullaceM. GhioS. Enriquez-SaranoM. TemporelliP.L. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.Heart201197201675168010.1136/hrt.2011.22578921807656
     [Google Scholar]
  56. SanninoA. SmithR.L.II SchiattarellaG.G. TrimarcoB. EspositoG. GrayburnP.A. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation.JAMA Cardiol.20172101130113910.1001/jamacardio.2017.297628877291
     [Google Scholar]
  57. BursiF. Enriquez-SaranoM. NkomoV.T. JacobsenS.J. WestonS.A. MeverdenR.A. RogerV.L. Heart failure and death after myocardial infarction in the community: The emerging role of mitral regurgitation.Circulation2005111329530110.1161/01.CIR.0000151097.30779.0415655133
     [Google Scholar]
  58. VahanianA. BeyersdorfF. PrazF. MilojevicM. BaldusS. BauersachsJ. CapodannoD. ConradiL. De BonisM. De PaulisR. DelgadoV. FreemantleN. GilardM. HaugaaK.H. JeppssonA. JüniP. PierardL. PrendergastB.D. SádabaJ.R. TribouilloyC. WojakowskiW. NeumannF-J. MyersP. AbdelhamidM. AchenbachS. AsteggianoR. BariliF. BorgerM.A. CarrelT. ColletJ-P. FoldagerD. HabibG. HassagerC. IrsA. IungB. JahangiriM. KatusH.A. KoskinasK.C. MassbergS. MuellerC.E. NielsenJ.C. PibarotP. RakishevaA. RoffiM. RubboliA. ShlyakhtoE. SiepeM. SitgesM. SondergaardL. Sousa-UvaM. TarantiniG. ZamoranoJ.L. PrazF. MilojevicM. BaldusS. BauersachsJ. CapodannoD. ConradiL. De BonisM. De PaulisR. DelgadoV. FreemantleN. GilardM. HaugaaK.H. JeppssonA. JüniP. PierardL. PrendergastB.D. SádabaJ.R. TribouilloyC. WojakowskiW. BenchabiY. ChilingaryanA. MetzlerB. RustamovaY. ShumavetsV. LancellottiP. SmajicE. Trendafilova-LazarovaD. SamardzicJ. KarakyriouM. PalecekT. Sanchez DahlJ. MeshaalM.S. PalmK. VirtanenM. BouletiC. BakhutashviliZ. AchenbachS. BoutsikouM. KertészA.B. DanielsenR. TopilskyY. GolinoP. TuleutayevR. EleziS. KerimkulovA. RudzitisA. GlaveckaiteS. SowR. DemarcoD.C. BulatovicN. AouadA. van den BrinkR. AntovaE. BeitnesJ.O. OchalaA. RibeirasR. VinereanuD. IrtyugaO. IvanovicB. SimkovaI. González GómezA. SarnoG. PedrazziniG.B. BsataW. ZakhamaL. KorkmazL. CherniukS. KhanjiM.Y. SharipovI. ESC/EACTS Scientific Document Group 2021 ESC/EACTS Guidelines for the management of valvular heart disease.Eur. Heart J.202243756163210.1093/eurheartj/ehab39534453165
     [Google Scholar]
  59. MaisanoF. TorraccaL. OppizziM. StefanoP.L. D’AddarioG. La CannaG. ZognoM. AlfieriO. The edge-to-edge technique: A simplified method to correct mitral insufficiency1.Eur. J. Cardiothorac. Surg.199813324024610.1016/S1010‑7940(98)00014‑19628372
     [Google Scholar]
  60. FeldmanT. FosterE. GlowerD.D. KarS. RinaldiM.J. FailP.S. SmallingR.W. SiegelR. RoseG.A. EngeronE. LoghinC. TrentoA. SkipperE.R. FudgeT. LetsouG.V. MassaroJ.M. MauriL. EVEREST II Investigators Percutaneous repair or surgery for mitral regurgitation.N. Engl. J. Med.2011364151395140610.1056/NEJMoa100935521463154
     [Google Scholar]
  61. ObadiaJ.F. Messika-ZeitounD. LeurentG. IungB. BonnetG. PiriouN. LefèvreT. PiotC. RouleauF. CarriéD. NejjariM. OhlmannP. LeclercqF. Saint EtienneC. TeigerE. LerouxL. KaramN. MichelN. GilardM. DonalE. TrochuJ.N. CormierB. ArmoiryX. BoutitieF. Maucort-BoulchD. BarnelC. SamsonG. GuerinP. VahanianA. MewtonN. MITRA-FR Investigators Percutaneous repair or medical treatment for secondary mitral regurgitation.N. Engl. J. Med.2018379242297230610.1056/NEJMoa180537430145927
     [Google Scholar]
  62. StoneG.W. LindenfeldJ. AbrahamW.T. KarS. LimD.S. MishellJ.M. WhisenantB. GrayburnP.A. RinaldiM. KapadiaS.R. RajagopalV. SarembockI.J. BriekeA. MarxS.O. CohenD.J. WeissmanN.J. MackM.J. COAPT Investigators Transcatheter mitral-valve repair in patients with heart failure.N. Engl. J. Med.2018379242307231810.1056/NEJMoa180664030280640
     [Google Scholar]
  63. ChehabO. Roberts-ThomsonR. Ng Yin LingC. MarberM. PrendergastB.D. RajaniR. RedwoodS.R. Secondary mitral regurgitation: Pathophysiology, proportionality and prognosis.Heart20201061071672310.1136/heartjnl‑2019‑31623832054671
     [Google Scholar]
  64. StoneG.W. AbrahamW.T. LindenfeldJ. KarS. GrayburnP.A. LimD.S. MishellJ.M. WhisenantB. RinaldiM. KapadiaS.R. RajagopalV. SarembockI.J. BriekeA. MarxS.O. CohenD.J. AschF.M. MackM.J. COAPT Investigators Five-year follow-up after transcatheter repair of secondary mitral regurgitation.N. Engl. J. Med.2023388222037204810.1056/NEJMoa230021336876756
     [Google Scholar]
  65. LimD.S. KarS. SpargiasK. KippermanR.M. O’NeillW.W. NgM.K.C. FamN.P. WaltersD.L. WebbJ.G. SmithR.L. RinaldiM.J. LatibA. CohenG.N. SchäferU. MarcoffL. VandrangiP. VertaP. FeldmanT.E. Transcatheter valve repair for patients with mitral regurgitation.JACC Cardiovasc. Interv.201912141369137810.1016/j.jcin.2019.04.03431255562
     [Google Scholar]
  66. WebbJ.G. HenseyM. SzerlipM. SchäferU. CohenG.N. KarS. MakkarR. KippermanR.M. SpargiasK. O’NeillW.W. NgM.K.C. FamN.P. RinaldiM.J. SmithR.L. WaltersD.L. RaffelC.O. LevisayJ. LatibA. MontorfanoM. MarcoffL. ShrivastavaM. BooneR. GilmoreS. FeldmanT.E. LimD.S. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.JACC Cardiovasc. Interv.202013202344235710.1016/j.jcin.2020.06.01933092709
     [Google Scholar]
  67. De BackerO. WongI. TaramassoM. MaisanoF. FranzenO. SøndergaardL. Transcatheter mitral valve repair: An overview of current and future devices.Open Heart202181e00156410.1136/openhrt‑2020‑00156433911022
     [Google Scholar]
  68. McInerneyA. Marroquin-DondayL. Tirado-ConteG. HennesseyB. EspejoC. PozoE. de AgustínA. GonzaloN. SalinasP. Núñez-GilI. Fernández-OrtizA. Mejía-RenteríaH. MacayaF. EscanedJ. Nombela-FrancoL. Jiménez-QuevedoP. Transcatheter treatment of mitral regurgitation.J. Clin. Med.20221110292110.3390/jcm1110292135629048
     [Google Scholar]
  69. YoonS.H. WhisenantB.K. BleizifferS. DelgadoV. DhobleA. SchoferN. EschenbachL. BansalE. MurdochD.J. AnconaM. SchmidtT. YzeirajE. VincentF. NiikuraH. KimW.K. AsamiM. UnbehaunA. HirjiS. FujitaB. SilaschiM. TangG.H.L. KuwataS. WongS.C. FrangiehA.H. BarkerC.M. DaviesJ.E. LautenA. DeuschlF. Nombela-FrancoL. RampatR. NiczP.F.G. MassonJ.B. WijeysunderaH.C. SievertH. BlackmanD.J. Gutierrez-IbanesE. SugiyamaD. ChakravartyT. Hildick-SmithD. de BritoF.S.Jr JensenC. JungC. SmallingR.W. ArnoldM. RedwoodS. KaselA.M. MaisanoF. TreedeH. EnsmingerS.M. KarS. KanekoT. PilgrimT. SorajjaP. Van BelleE. PrendergastB.D. BapatV. ModineT. SchoferJ. FrerkerC. KempfertJ. AttizzaniG.F. LatibA. SchaeferU. WebbJ.G. BaxJ.J. MakkarR.R. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.Eur. Heart J.201940544145110.1093/eurheartj/ehy59030357365
     [Google Scholar]
  70. HenseyM. BrownR.A. LalS. SathananthanJ. YeJ. CheungA. BlankeP. LeipsicJ. MossR. BooneR. WebbJ.G. Transcatheter mitral valve replacement.JACC Cardiovasc. Interv.202114548950010.1016/j.jcin.2020.12.03833663778
     [Google Scholar]
  71. YoonS.H. BleizifferS. LatibA. EschenbachL. AnconaM. VincentF. KimW.K. UnbehaumA. AsamiM. DhobleA. SilaschiM. FrangiehA.H. VeulemansV. TangG.H.L. KuwataS. RampatR. SchmidtT. PatelA.J. NiczP.F.G. Nombela-FrancoL. KiniA. KitamuraM. SharmaR. ChakravartyT. Hildick-SmithD. ArnoldM. de BritoF.S.Jr JensenC. JungC. JilaihawiH. SmallingR.W. MaisanoF. KaselA.M. TreedeH. KempfertJ. PilgrimT. KarS. BapatV. WhisenantB.K. Van BelleE. DelgadoV. ModineT. BaxJ.J. MakkarR.R. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement.JACC Cardiovasc. Interv.201912218219310.1016/j.jcin.2018.12.00130678797
     [Google Scholar]
  72. WebbJ. HenseyM. FamN. Rodés-CabauJ. DanielsD. SmithR. SzetoW. BooneR. YeJ. MossR. PetersonM. OngG. ParadisJ.M. DagenaisF. Wintzer-WehekindJ. ShafiB. NairD. SzerlipM. GrayburnP. SilvestryF. KoulogiannisK. HermillerJ. GuytonR. HerrmannH. Transcatheter mitral valve replacement with the transseptal EVOQUE system.JACC Cardiovasc. Interv.202013202418242610.1016/j.jcin.2020.06.04033092713
     [Google Scholar]
  73. BenfariG. AntoineC. MillerW.L. ThapaP. TopilskyY. RossiA. MichelenaH.I. PislaruS. Enriquez-SaranoM. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction.Circulation2019140319620610.1161/CIRCULATIONAHA.118.03894631117814
     [Google Scholar]
  74. KilicA. Saha-ChaudhuriP. RankinJ.S. ConteJ.V. Trends and outcomes of tricuspid valve surgery in North America: An analysis of more than 50,000 patients from the Society of Thoracic Surgeons database.Ann. Thorac. Surg.20139651546155210.1016/j.athoracsur.2013.06.03124070702
     [Google Scholar]
  75. MesnierJ. AlperiA. PanagidesV. BédardE. SalaunE. PhilipponF. Rodés-CabauJ. Transcatheter tricuspid valve interventions: Current devices and associated evidence.Prog. Cardiovasc. Dis.2021698910010.1016/j.pcad.2021.11.00734801577
     [Google Scholar]
  76. TaramassoM. BenfariG. van der BijlP. AlessandriniH. Attinger-TollerA. BiascoL. LurzP. BraunD. BrochetE. ConnellyK.A. de BruijnS. DentiP. DeuschlF. Estevez-LoureiroR. FamN. FrerkerC. GavazzoniM. HausleiterJ. HoE. JuliardJ.M. KapleR. BeslerC. KodaliS. KreidelF. KuckK.H. LatibA. LautenA. MonivasV. MehrM. Muntané-CarolG. NazifT. NickeningG. PedrazziniG. PhilipponF. PozzoliA. PrazF. PuriR. Rodés-CabauJ. SchäferU. SchoferJ. SievertH. TangG.H.L. ThieleH. TopilskyY. RommelK.P. DelgadoV. VahanianA. Von BardelebenR.S. WebbJ.G. WeberM. WindeckerS. WinkelM. ZuberM. LeonM.B. HahnR.T. BaxJ.J. Enriquez-SaranoM. MaisanoF. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation.J. Am. Coll. Cardiol.201974242998300810.1016/j.jacc.2019.09.02831568868
     [Google Scholar]
  77. LurzP. Stephan von BardelebenR. WeberM. SitgesM. SorajjaP. HausleiterJ. DentiP. TrochuJ.N. NabauerM. TangG.H.L. BiaggiP. YingS.W. TrustyP.M. DahouA. HahnR.T. NickenigG. TRILUMINATE Investigators Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation.J. Am. Coll. Cardiol.202177322923910.1016/j.jacc.2020.11.03833478646
     [Google Scholar]
  78. LurzP. BeslerC. SchmitzT. BekeredjianR. NickenigG. MöllmannH. von BardelebenR.S. SchmeisserA. AtmowihardjoI. Estevez-LoureiroR. LubosE. HeitkemperM. HuangD. LappH. DonalE. AdamoM. GolinoP. MelicaB. RudolphV. CortiR. FreixaX. ArzamendiD. PrazF. CastriotaF. VeienK. KowalskiM. RensingB. SchoferN. ZirlikA. RottbauerW. bRIGHT PAS Principal Investigators Short-term outcomes of tricuspid edge-to-edge repair in clinical practice.J. Am. Coll. Cardiol.202382428129110.1016/j.jacc.2023.05.00837207923
     [Google Scholar]
  79. KodaliS. HahnR.T. EleidM.F. KippermanR. SmithR. LimD.S. GrayW.A. NarangA. PislaruS.V. KoulogiannisK. GrayburnP. FowlerD. HawthorneK. DahouA. DeoS.H. VandrangiP. DeuschlF. MackM.J. LeonM.B. FeldmanT. DavidsonC.J. CLASP TR EFS Investigators Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation.J. Am. Coll. Cardiol.202177434535610.1016/j.jacc.2020.11.04733509390
     [Google Scholar]
  80. AlperiA. AlmendárezM. ÁlvarezR. MorisC. LeonV. SilvaI. Hernández-VaqueroD. PascualI. AvanzasP. Transcatheter tricuspid valve interventions: Current status and future perspectives.Front. Cardiovasc. Med.2022999450210.3389/fcvm.2022.99450236187002
     [Google Scholar]
  81. Abdul-Jawad AltisentO. BenetisR. RumbinaiteE. MizarienV. CodinaP. Gual-CapllonchF. SpitaleriG. Fernandez-NofreriasE. Bayes-GenisA. PuriR. Caval valve implantation (CAVI): An emerging therapy for treating severe tricuspid regurgitation.J. Clin. Med.20211019460110.3390/jcm1019460134640619
     [Google Scholar]
  82. LautenA. DregerH. LauleM. StanglK. FigullaH.R. EngM.H. Caval valve implantation.Interv. Cardiol. Clin.20221119510234838301
     [Google Scholar]
  83. Estévez-LoureiroR. Sánchez-RecaldeA. Amat-SantosI.J. Cruz-GonzálezI. BazJ.A. PascualI. MascherbauerJ. Abdul-Jawad AltisentO. Nombela-FrancoL. PanM. TrilloR. MorenoR. Delle KarthG. Salido-TahocesL. Santos-MartinezS. NúñezJ.C. MorisC. GoliaschG. Jimenez-QuevedoP. OjedaS. Cid-ÁlvarezB. Santiago-VacasE. Jimenez-ValeroS. SerradorA. Martín-MoreirasJ. StrouhalA. HengstenbergC. ZamoranoJ.L. PuriR. Íñiguez-RomoA. 6- month outcomes of the tricvalve system in patients with tricuspid regurgitation.JACC Cardiovasc. Interv.202215131366137710.1016/j.jcin.2022.05.02235583363
     [Google Scholar]
  84. DregerH. MattigI. HewingB. KnebelF. LautenA. LembckeA. ThoenesM. RoehleR. StanglV. LandmesserU. GrubitzschH. StanglK. LauleM. Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien xt valve (TRICAVAL): A randomised controlled trial.EuroIntervention202015171506151310.4244/EIJ‑D‑19‑0090131929100
     [Google Scholar]
  85. NickenigG. FriedrichsK.P. BaldusS. ArnoldM. SeidlerT. HakmiS. LinkeA. SchäferU. DregerH. ReinthalerM. von BardelebenR.S. MöllmannH. WeberM. RoderF. KörberM.I. LandendingerM. WolfF. AlessandriniH. SvericK. SchewelD. Romero-DortaE. KasnerM. DahouA. HahnR.T. WindeckerS. Thirty-day outcomes of the cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study.EuroIntervention2021171080981710.4244/EIJ‑D‑21‑0030034031021
     [Google Scholar]
  86. RadhoeS.P. VeenisJ.F. BrugtsJ.J. Invasive devices and sensors for remote care of heart failure patients.Sensors2021216201410.3390/s2106201433809205
     [Google Scholar]
  87. BourgeR.C. AbrahamW.T. AdamsonP.B. AaronM.F. ArandaJ.M.Jr MagalskiA. ZileM.R. SmithA.L. SmartF.W. O’ShaughnessyM.A. JessupM.L. SparksB. NaftelD.L. StevensonL.W. COMPASS-HF Study Group Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study.J. Am. Coll. Cardiol.200851111073107910.1016/j.jacc.2007.10.06118342224
     [Google Scholar]
  88. AdamsonP.B. GoldM.R. BennettT. BourgeR.C. StevensonL.W. TruppR. StrombergK. WilkoffB.L. CostanzoM.R. LubyA. ArandaJ.M. HeywoodJ.T. BaldwinH.A. AaronM. SmithA. ZileM. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: Results of the reducing decompensation events utilizing intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial.Congest. Heart Fail.201117524825410.1111/j.1751‑7133.2011.00247.x21906250
     [Google Scholar]
  89. AbrahamW.T. AdamsonP.B. BourgeR.C. AaronM.F. CostanzoM.R. StevensonL.W. StricklandW. NeelagaruS. RavalN. KruegerS. WeinerS. ShavelleD. JeffriesB. YadavJ.S. CHAMPION Trial Study Group Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial.Lancet2011377976665866610.1016/S0140‑6736(11)60101‑321315441
     [Google Scholar]
  90. AbrahamW.T. AdamsonP.B. CostanzoM.R. EiglerN. GoldM. KlapholzM. MaurerM. SaxonL. SinghJ. TroughtonR. Hemodynamic monitoring in advanced heart failure: Results from the LAPTOP-HF trial.J. Card. Fail.2016221194010.1016/j.cardfail.2016.09.012
     [Google Scholar]
  91. UdelsonJ.E. BarkerC.M. MeduriC. FailP.S. SoletD. KriegelJ. ShaburishviliT. Six month results from first in human clinical experience of a no-implant interatrial shunt for heart failure with preserved ejection fraction.J. Am. Coll. Cardiol.2022799Suppl.22922910.1016/S0735‑1097(22)01220‑7
     [Google Scholar]
  92. Rod ésCJ. Bernier M. Amat -Santos IgnacioJ. Interatrial shunting for heart failure.JACC Cardiovasc Interv201811223002310
     [Google Scholar]
  93. KayeD.M. NanayakkaraS. Interatrial shunt device for heart failure with preserved ejection fraction.Front. Cardiovasc. Med.2019614310.3389/fcvm.2019.0014331620452
     [Google Scholar]
  94. YiT. LiM. FanF. QiuL. WangZ. WengH. ShangX. ZhangC. MaW. ZhangY. HuoY. Haemodynamic changes of interatrial shunting devices for heart failure: A systematic review and meta-analysis.ESC Heart Fail.2022931987199510.1002/ehf2.1391135322588
     [Google Scholar]
  95. FeldmanT. MauriL. KahwashR. LitwinS. RicciardiM.J. van der HarstP. PenickaM. FailP.S. KayeD.M. PetrieM.C. BasurayA. HummelS.L. Forde-McLeanR. NielsenC.D. LillyS. MassaroJ.M. BurkhoffD. ShahS.J. REDUCE LAP-HF I Investigators and Study Coordinators Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [reduce elevated left atrial pressure in patients with heart failure]).Circulation2018137436437510.1161/CIRCULATIONAHA.117.03209429142012
     [Google Scholar]
  96. ShahS.J. BorlaugB.A. ChungE.S. CutlipD.E. DebonnaireP. FailP.S. GaoQ. HasenfußG. KahwashR. KayeD.M. LitwinS.E. LurzP. MassaroJ.M. MohanR.C. RicciardiM.J. SolomonS.D. SverdlovA.L. SwarupV. van VeldhuisenD.J. WinklerS. LeonM.B. AkarJ. AndoJ. AnzaiT. AsakuraM. BaileyS. BasurayA. BauerF. BergmannM. BlairJ. CavendishJ. ChungE. CikesM. DauberI. DonalE. EicherJ-C. FailP. FlahertyJ. FreixaX. GafoorS. GertzZ. GordonR. GuazziM. Guerrero-MirandaC. GuptaD. GustafssonF. HadadiC. HakemiE. HandokoL. HassM. HausleiterJ. HaywardC. HickeyG. HummelS. HussainI. IsnardR. IzumiC. JondeauG. JunemanE. KinugawaK. KippermanR. KrakowiakB. KrimS. LarnedJ. LewisG. LipsicE. MagalskiA. MazimbaS. MazurekJ. McGradyM. MckenzieS. MehtaS. MignoneJ. MorsliH. NairA. NoelT. OrfordJ. ParikhK. PattersonT. PenickaM. PetrieM. PieskeB. PostM. RaakeP. RomeroA. RyanJ. SaitoY. SakamotoT. SakataY. SamaraM. SatyaK. SindoneA. StarlingR. TrochuJ-N. UpadhyaB. van der HeydenJ. van EmpelV. VarmaA. VestA. WengenmayerT. WestenfeldR. WestermannD. YamamotoK. ZirlikA. REDUCE LAP-HF II investigators Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): A randomised, multicentre, blinded, sham-controlled trial.Lancet2022399103301130114010.1016/S0140‑6736(22)00016‑235120593
     [Google Scholar]
  97. AdhyapakS.M. ParachuriV.R. Architecture of the left ventricle: Insights for optimal surgical ventricular restoration.Heart Fail. Rev.2010151738310.1007/s10741‑009‑9151‑019757029
     [Google Scholar]
  98. RangaswamiJ. BhallaV. BlairJ.E.A. ChangT.I. CostaS. LentineK.L. LermaE.V. MezueK. MolitchM. MullensW. RoncoC. TangW.H.W. McCulloughP.A. American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the american heart association.Circulation201913916e840e87810.1161/CIR.000000000000066430852913
     [Google Scholar]
  99. MullensW. AbrahamsZ. FrancisG.S. SokosG. TaylorD.O. StarlingR.C. YoungJ.B. TangW.H.W. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.J. Am. Coll. Cardiol.200953758959610.1016/j.jacc.2008.05.06819215833
     [Google Scholar]
  100. NijstP. MartensP. DupontM. TangW.H.W. MullensW. Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients.JACC Heart Fail.20175967268110.1016/j.jchf.2017.05.00628711449
     [Google Scholar]
  101. VoraA.N. Schuyler JonesW. DeVoreA.D. EbnerA. CliftonW. PatelM.R. First-in-human experience with Aortix intraaortic pump.Catheter. Cardiovasc. Interv.201993342843310.1002/ccd.2785730311400
     [Google Scholar]
  102. ZymlińskiR. DierckxR. BiegusJ. VanderheydenM. BartunekJ. PonikowskiP. Novel IVC doraya catheter provides congestion relief in patients with acute heart failure.JACC Basic Transl. Sci.20227332632710.1016/j.jacbts.2022.02.01335411326
     [Google Scholar]
  103. MaronM.S. OlivottoI. BetocchiS. CaseyS.A. LesserJ.R. LosiM.A. CecchiF. MaronB.J. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.N. Engl. J. Med.2003348429530310.1056/NEJMoa02133212540642
     [Google Scholar]
  104. MaronM.S. OmmenS.R. Exploring new and old therapies for obstructive hypertrophic cardiomyopathy.Circulation2021143121181118310.1161/CIRCULATIONAHA.120.05133033750209
     [Google Scholar]
  105. ZhouM. TaS. HahnR.T. HsiD.H. LeonM.B. HuR. ZhangJ. ZuoL. LiJ. WangJ. WangB. ZhuX. LiuJ. HanY. LiX. XuB. ZhangL. HouL. HanC. LiuJ. LiuL. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy.JAMA Cardiol.20227552953810.1001/jamacardio.2022.025935353129
     [Google Scholar]
  106. KhanJ.M. BruceC.G. GreenbaumA.B. Transcatheter myotomy to relieve left ventricular outflow tract obstruction: The septal scoring along the midline endocardium procedure in animals.Circ. Cardiovasc. Interv.2022156e01168610.1161/CIRCINTERVENTIONS.121.01168635378990
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128284131240209113009
Loading
Pharmacological Considerations during Percutaneous Treatment of Heart Failure
Curr. Pharm. Des. 30, 565 (2024); https://doi.org/10.2174/0113816128284131240209113009
/content/journals/cpd/10.2174/0113816128284131240209113009
/content/journals/cpd/10.2174/0113816128284131240209113009
Loading

Data & Media loading...

  • Article Type: Review Article
Keyword(s): cardiogenic shock; ECMO; Heart failure; Impella; interventional cardiology; MitraClip; TandemHeart; TriClip

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test